DNA repair

August 8, 2017August 8, 2017

Breast, Ovarian Cancer Therapies Induce Malignant Pleural Mesothelioma Cell Death, Study Shows

News

Tesaro (niraparib) and Lymparza (olaparib) — both PARP1 inhibitors approved by the U.S. Food and Drug Administration to treat breast and ovarian cancer patients — also kill malignant pleural mesothelioma (MPM) ... Read more

July 12, 2017July 12, 2017

Mutations in DNA Repair Genes Linked to Likelihood of Mesothelioma Upon Asbestos Exposure in Study

News

Inherited mutations in the genes responsible for the maintenance and repair of a cell’s DNA can help explain why some people develop malignant pleural mesothelioma (MPM) upon asbestos exposure while others don’t. ... Read more